A study to evaluate the efficacy and safety of Tolvaptan and Carperitide in HF patients
Not Applicable
- Conditions
- congestive heart failure
- Registration Number
- JPRN-UMIN000008257
- Lead Sponsor
- Yokohama Sakae Kyosai Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
(1) history of allergy against this drug or similar compounds (2) anuric patients (3) patients who cannot feel thirsty or have difficulty to drink (4) hypernatremia patients (5) patients who are pregnant or possibly pregnant (6) patients who already have tolvaptan at entry (7) acute myocardial infarction patients or planned revascularization during study period (8) patiets who administer intravenous diuretics except carperitide (9) patients who are judged to be inappropriate to this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method change in urine volume
- Secondary Outcome Measures
Name Time Method Congestive symptoms, renal function, neurohumoral factors, safety and cardiovascular events